The Single-use Gastroscopes industry trends over the past 18 months reflect a dynamic market driven by technological innovation and strategic collaborations. Companies have prioritized expanding access to cost-effective, infection-control-focused solutions, with key partnerships such as Olympus Corporation and Pentax Medical strengthening distribution networks in emerging markets. Medtronic notably acquired Given Imaging to bolster its endoscopy portfolio, while Ambu A/S launched the Single-Use Gastroscope (SUG) with enhanced imaging capabilities, addressing unmet clinical needs. Regulatory shifts, including the FDAโs 2023 updates on reusable scope reprocessing standards, have accelerated adoption of single-use alternatives. Meanwhile, enterprises are investing in AI-integrated diagnostics, with Boston Scientific securing $150M in funding to advance AI-driven gastroscopy platforms. Consumer demand is tilting toward disposable solutions amid hospital budget pressures and rising GI disorder prevalence, signaling a structural shift toward streamlined workflows and reduced cross-contamination risks.